Company Filing History:
Years Active: 1999
Title: Ree An Yoo: Innovator in Vaccine Development
Introduction
Ree An Yoo is a notable inventor based in Kwachun, South Korea. He has made significant contributions to the field of vaccine development, particularly in relation to Pseudomonas aeruginosa infections. His innovative work has led to the creation of a vaccine that utilizes attenuated strains of this bacterium.
Latest Patents
Ree An Yoo holds a patent for a process for preparing a vaccine against Pseudomonas aeruginosa. This invention involves isolating Pseudomonas aeruginosa in a pure state according to the Fisher-Devlin immunotype and purifying the isolated strain. The patent specifically mentions several strains, including CFCPA 10142, CFCPA 20215, CFCPA 30720, CFCPA 40057, CFCPA 50243, CFCPA 60534, and CFCPA 70018. The vaccine is designed for immunization against Pseudomonas aeruginosa infection and contains cell wall proteins with molecular weights ranging from 10,000 to 100,000. These proteins are non-pathogenic, safe, and exhibit excellent antibody formation capacity, making them useful for vaccine and therapeutic agent preparation.
Career Highlights
Ree An Yoo is associated with Cheiljedang Corporation, where he continues to advance his research in vaccine development. His work has garnered attention for its potential impact on public health, particularly in combating infections caused by Pseudomonas aeruginosa.
Collaborations
Ree An Yoo collaborates with several professionals in his field, including Hyun Su Kim and Wan Je Park. Their combined expertise contributes to the innovative research and development efforts at Cheiljedang Corporation.
Conclusion
Ree An Yoo's contributions to vaccine development highlight the importance of innovation in addressing infectious diseases. His work not only advances scientific knowledge but also has the potential to improve health outcomes for many individuals.